Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 24.19M
June 30, 2026 -2.967M
March 31, 2026 -17.72M
December 31, 2025 13.23M
September 30, 2025 35.57M
June 30, 2025 33.83M
March 31, 2025 29.40M
December 31, 2024 22.29M
September 30, 2024 -61.32M
June 30, 2024 -17.98M
March 31, 2024 27.10M
December 31, 2023 37.38M
September 30, 2023 38.43M
June 30, 2023 39.13M
Date Value
March 31, 2023 29.50M
December 31, 2022 -6.507M
September 30, 2022 46.05M
June 30, 2022 -124.46M
March 31, 2022 -159.41M
December 31, 2021 9.673M
September 30, 2021 -47.33M
June 30, 2021 77.09M
March 31, 2021 -3.261M
December 31, 2020 -100.22M
September 30, 2020
June 30, 2020
March 31, 2020 -1.021M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Anavex Life Sciences Corp. 0.00
Vaxcyte, Inc. 170.77M
Connect Biopharma Holdings Ltd. 1.517M
Caribou Biosciences, Inc. 19.39M
Oncolytics Biotech, Inc. -0.0069M